Evaluating a Noise Reduction Algorithm With Cochlear Implant Users
Launched by NYU LANGONE HEALTH · Mar 23, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new noise reduction technology designed to help cochlear implant users, who have difficulty hearing, understand speech better in noisy environments. If you're 12 years old or older and have received a cochlear implant at least six months ago, you may be eligible to participate in this study. The trial is open to individuals regardless of the cochlear implant brand they use.
Participants in the trial will experience different listening situations to see how well the noise reduction works in helping them understand speech. The goal is to find out if this technology makes it easier for people with hearing impairments to communicate in everyday situations. If you or a family member are interested and meet the eligibility criteria, this could be a valuable opportunity to contribute to improving hearing technology for others.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 12 years of age.
- • Be post-lingually deafened cochlear implant recipients with at least 6 months experience regardless of manufacturer.
- • The PI must also deem the child to be developmentally able to complete the experiments.
- Exclusion Criteria:
- • • Anyone who is not a cochlear implant user or is aged under 12 years.
About Nyu Langone Health
NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
David M. Landsberger
Principal Investigator
NYU Langone Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials